Abstract Clinical studies suggest that hyperhomocysteinemia could be considered an independent risk factor for premature cerebral, peripheral and vascular diseases. A number of authors found an epidemiological correlation between increased risk of cerebrovascular disease and migraine with aura. In this study, 34 patients suffering from migraine with aura and 36 healthy controls were evaluated with respect to total plasma homocysteine levels, measured with FPIA immunoassay in the fasting state and after methionine load.
Moreover, vitamin B12, folate and other classic biochemical indicators of atherosclerosis disease were evaluated. In this study, homocysteine levels, both at basal and after load, and other cardiovascular risk factors such as vitamin B12 and apo-LpA were within the normal range. Other multicentric randomised trials are needed to carry on and confirm these data. Table 1 .
Homocysteine is an intermediate amino acid formed during the metabolism of methionine, an essential sulfur-containing amino acid supplied from dietary proteins. A large complex of enzymes and cofactors (vitamin B12, B6 and folate) is necessary to maintain homocysteine at normal serum levels (Fig. 1) .
In this study we evaluated the homocysteine levels in patients suffering from migraine with aura and in normal subjects, to detect possible alterations of homocysteine plasma levels at basal time and after methionine oral load. At the same time, we collected information about "classic" plasmatic markers of cardiovascular risk.
Materials and methods

Patients and controls
We recruited 34 migraine patients (Table 2) , evaluated in the intercritical period, 12 men and 22 women, aged 18-60 years (mean, 37.8 years; SD=11.8 years) from the Headache Center at our hospital; 6% of patients were smokers. The mean body mass index was 24.28 kg/m 2 (SD=4.32 kg/m 2 ). Mean blood pressure was 127±18 mmHg (systolic) and 83±12 mmHg (diastolic). 18% of patient's relatives referred migraine (5% with aura) and only 10% of women assumed oral contraceptives. The diagnosis of migraine with aura (MwA) was performed according to the International Headache Society (IHS) classification [20] . The frequency of attacks ranged between 3 and 20 per year, with an average of 5 attacks/year. A total of 36 healthy age-and sex-matched volunteers comprised the control group (11 men and 25 women); mean age was 42.1 years (SD=12.6 years).
Biochemical data
Total plasma homocysteine levels were measured with FPIA immunoassay (Imx Abbott Analyzer) both in the fasting state (baseline, time 0) and after methionine load (4 h) [21] [22] [23] . Hyperhomocysteinemia 2-8 h after an oral methionine load (standard dose, 0.1 g/kg body weight of L-methionine mixed in fruit juice) may identify individuals at increased risk for vascular disease despite normal fasting total plasma homocysteine concentrations (an additional 27% of at-risk cases).
Hyperhomocysteinemia is usually defined by using an arbitrary cut-off; normal plasma homocysteine levels range from 5 to 13 µmol/l. Men have higher concentrations of homocysteine than women (1 µmol/l), and amounts of homocysteine tend to increase slightly with age [24] .
Clinical information was obtained by a direct interview from all the patients responding to questionnaire items on other risk factors: body mass index (BMI), cardiovascular disease, hypertension (basal blood pressure, BP), diabetes mellitus, smoking, familiar history of premature cardiovascular disease or migraine, and actual use of medication (e.g. oral contraceptives) ( Table 2) .
In addition to the classic lipid levels (total cholesterol, HDLcholesterol, LDL-cholesterol, triglycerides), we also evaluated other risk factors for atherosclerosis, such as apolipoproteins A1 and B, fibrinogen, vitamin B12 and folate. These have a significant role as nutrients which impact on homocysteine metabolism.
Statistical analysis
Data were analysed using the t test, and are expressed as mean and standard deviation in tables and text. 
Results
A baseline homocysteine level higher than 13 µmol/l (<13 under 60 years, <20 over 60) or a pathological difference between the basal value and the post-load value (>27 µmol/l) is considered an indicator of high risk for cardiovascular disease. In Table 3 , we report the homocysteine data of our patients. The others plasmatic parameters of cardiovascular risk are reported in Table 4 .
Discussion
Although there is evidence from epidemiological studies supporting a positive relationship between elevated plasma homocysteine and coronary heart disease, and between migraine and stroke (in women, under 45 years of age [11, 12] ), these studies are inconsistent and not univocal, because of differences in study design, methodological or statistical power and chance (publication bias) [2] . It remains to be demonstrated that reducing elevated plasma homocysteine levels will result in a reduction in the risk for cardiovascular disease. Moreover, the definition of elevated homocysteine levels is not standardized, and substantial differences exist in the "normal" reference used in the literature (day-to-day, postprandial, orthostatic, intra-and inter-individual variations).
In this study, despite the small series, we found no significant difference between migraine with aura patients and controls with respect to episodes of stroke or other vascular diseases. Only in one case was homocysteine over the normal range. The patient was a 45-year-old woman suffering from migraine with prolonged aura, with a familial history of migraine and diabetes mellitus, but not for myocardial infarction or stroke. Her lifestyle was free from alcohol and tobacco smoke, dietary intake was correct, and neuroimaging results were normal.
There are reports suggesting that vitamins are related to progression of atherosclerosis and variation of circulating homocysteine [17, 18] . Therefore, the use of folic acid, vitamin B6 and B12 supplementation was proposed to normalize the pathologically high homocysteine levels, although there is no clear evidence that treatment with vitamins alters progression of atherosclerosis or reduces cardiovascular events [17] [18] [19] .
In our study homocysteine levels and other cardiovascular risk factors such as vitamin B12 and apo-LpA were within the normal ranges and were not related to the presence of migraine with aura. Although this study shows a negative relationship between migraine with aura and homocysteine, in the literature there are some reports referring these correlations. The association between homocysteine levels and migraine is less documented than that between migraine and stroke. Therefore, careful multicentric randomized trials with a large number of patients are needed to establish whether migraine with aura may be associated with a significant risk for cardiovascular disease and, in case of positive results, to define the prognostic and predictive values of serum homocysteine in these patients. In conclusion, lacking positive evidence, this test has no pathognomonic indication in patients suffering from migraine with aura. 
